Encrylin 5mg (10 Tablet / Pack)

A selective oral DPP-4 inhibitor antihyperglycemic agent indicated for managing Type 2 Diabetes Mellitus.

PKR 250.00

You save: PKR 0

Quantity:

SKU: ENCRYLIN_5MG_10_TABLET_PACK

Category: Tablets & Capsules

Encrylin 5mg (10 Tablet / Pack) contains Linagliptin, a highly selective, potent dipeptidyl peptidase-4 (DPP-4) inhibitor engineered for the comprehensive management of Type 2 Diabetes Mellitus. By preventing the enzymatic degradation of incretin hormones (GLP-1 and GIP), it increases glucose-dependent insulin secretion from pancreatic beta cells while suppressing inappropriate glucagon release from alpha cells.

Purpose

Prolongs active systemic incretin levels to boost glucose-dependent insulin release and suppress hepatic glucose production.

Ingredients

Linagliptin 5mg

Warnings

Utilize strictly as an auxiliary adjunct to a structured, clinician-approved dietary plan and routine physical exercise program. Monitor the patient closely for severe, unyielding abdominal pain that could clinically indicate the development of acute pancreatitis. Unlike other antidiabetic agents, linagliptin is primarily eliminated unchanged via bile and feces, requiring no renal dose adjustments. Co-administration with insulin or sulfonylureas can dramatically amplify hypoglycemia risks, necessitating a baseline dose reduction.

Side Effects

Mild nasopharyngitis, upper respiratory tract irritation, or low-grade dry coughing. Transient joint pain (arthralgia) or localized musculoskeletal discomfort. Minor, self-limiting nausea, low-grade flatulence, or mild abdominal fullness. Potential for localized hypersensitivity reactions including low-grade pruritus or minor rashes.